Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Syngenta Corn Class Action Lawsuits Filed Over Genetically Modified Seeds November 12, 2014 Irvin Jackson Add Your Comments A growing number of corn farmers and exporters are pursuing lawsuits over Syngenta GMO seed products, alleging that genetically modified seed sold in recent years has contaminated the U.S. corn supply and resulted in catastrophic damages for the entire industry due to the inability to export corn to China. Since 2009, Syngenta has been marketing genetically modified (GMO) corn seed products known as “Agisure Viptera” and “Agisure Duracade”, which contain an engineered trait called MIR162. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Class action lawsuits have been filed throughout the country in recent weeks on behalf of farmers and exporters, alleging that Syngenta CMO corn seed may cause the farm industry to suffer damages between $1 billion and $2.9 billion. One of the most recent complaints (PDF) was brought this week in the U.S. District Court for the Eastern District of North Carolina by a group of local corn farmers, who allege that they have sustained substantial damages due to drops in corn prices and the loss of export markets. “Plaintiffs and those similarly situated have incurred losses arising from the rejection of U.S. grown corn by export markets,” according to the lawsuit filed on November 11. “[Plaintiffs] have sustained damage to their farmland and entire farming operations. And because the substantial portion of the U.S. corn crop is exported annually, the United States ability and limitations on corn exports deeply impacts corn price levels, including domestic prices in the corn market.” Syngenta Corn Seed Problems Known as GMO corn seed, Syngenta Agisure Viptera and Agisure Duracade were marketed to protect against damage from certain pests and make the corn more adapted to surviving. However, Syngenta launched the corn seed without first obtaining approval for the genetically modified corn to be exported to China, which is the third-largest market for U.S. corn exports in the world. Although Syngenta GMO corn seed products only account for a limited portion of the U.S. market, cross pollination and co-mingling of corn grown by individual farmers in grain elevators, distribution centers, trains and other transportation containers have resulted in the genetically modified trait contaminating much of the U.S. corn supply, according to a growing number of lawsuits filed nationwide. Since the beginning of the month, nearly a dozen complaints have been filed in courts throughout the United States, raising similar allegations that Syngenta negligently and recklessly marketed Agisure Viptera and Agisure Duracade corn seed, encouraging farmers to plant the genetically modified corn side-by-side with other corn seed products and falsely claiming that regulatory approval in China was imminent. The North Carolina lawsuit points out that during a first quarter earnings call in 2012, Syngenta CEO Michael Mack told investors “[t]here isn’t outstanding approval for China, which we expect to have quite frankly within the matter of a couple days…we know of no issue with that whatsoever…” Exports account for about 20% of corn grown in the United States. In recent years, the China corn market has been the fastest growing in the world, with expectations that it would become the largest export market within the next decade. In November 2013, China began rejecting corn shipments from the United States, after detecting even a trace amount of Syngenta modified corn. “[A]s a result of China’s prohibition on the importation of MIR162 corn, even in trace, low-level amounts, and Syngenta’s decision to continue marketing MIR162 to a small minority of U.S. corn farmers — the vast majority of U.S. corn has been effectively excluded from what was previously the third-largest export market for U.S. corn, causing U.S. farmers significant damages as corn prices have dropped from the loss of China’s export markets,” according to another class action lawsuit (PDF) filed by Charlynn Hamilton in Nebraska federal court on November 3. “Moreover, although it knew that it lacked approval from Chinese authorities, Syngenta has misinformed farmers, grain elevators, grain exporters, and the general public into believing that regulatory approval of MIR162 corn from China was imminent and that the lack of Chinese approval would not impact the corn market prices.” In addition to lawsuits by farmers in at least a dozen different states, Syngenta also faces claims by grain exporters, including Cargill Inc. and Trans Coastal Supply Co. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Class Action Lawsuit, Genetically Modified Organisms, GMOs, Syngenta, Viptera More Syngenta Corn Lawsuit Stories Syngenta Corn Seed Settlement to Result in $1.4B in Payments to U.S. Farmers September 27, 2017 Syngenta Corn Seed Lawsuit Results in $218 Million Verdict for Farmers June 26, 2017 Syngenta Lawsuits Over Viptera, Duracade Corn Seed Allowed to Move Forward September 24, 2015 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermURLThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: 2 days ago) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025) Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 3 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025) Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 4 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)
Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: 2 days ago) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025)
Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 3 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 4 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)